Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 5
2012 7
2013 4
2014 6
2015 26
2016 18
2017 16
2018 10
2019 17
2020 11
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 32675303

101 results
Results by year
Filters applied: . Clear all
Page 1
Kidney Disease-Associated APOL1 Variants Have Dose-Dependent, Dominant Toxic Gain-of-Function.
Datta S, Kataria R, Zhang JY, Moore S, Petitpas K, Mohamed A, Zahler N, Pollak MR, Olabisi OA. Datta S, et al. J Am Soc Nephrol. 2020 Jul 16:ASN.2020010079. doi: 10.1681/ASN.2020010079. Online ahead of print. J Am Soc Nephrol. 2020. PMID: 32675303
APOL1 and kidney cell function.
Kumar V, Singhal PC. Kumar V, et al. Am J Physiol Renal Physiol. 2019 Aug 1;317(2):F463-F477. doi: 10.1152/ajprenal.00233.2019. Epub 2019 Jun 26. Am J Physiol Renal Physiol. 2019. PMID: 31241995 Free PMC article. Review.
APOL1 kidney disease risk variants cause cytotoxicity by depleting cellular potassium and inducing stress-activated protein kinases.
Olabisi OA, Zhang JY, VerPlank L, Zahler N, DiBartolo S 3rd, Heneghan JF, Schlöndorff JS, Suh JH, Yan P, Alper SL, Friedman DJ, Pollak MR. Olabisi OA, et al. Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):830-7. doi: 10.1073/pnas.1522913113. Epub 2015 Dec 23. Proc Natl Acad Sci U S A. 2016. PMID: 26699492 Free PMC article.
ApoL1 Overexpression Drives Variant-Independent Cytotoxicity.
O'Toole JF, Schilling W, Kunze D, Madhavan SM, Konieczkowski M, Gu Y, Luo L, Wu Z, Bruggeman LA, Sedor JR. O'Toole JF, et al. J Am Soc Nephrol. 2018 Mar;29(3):869-879. doi: 10.1681/ASN.2016121322. Epub 2017 Nov 27. J Am Soc Nephrol. 2018. PMID: 29180397 Free PMC article.
APOL1 Kidney Risk Variants Induce Cell Death via Mitochondrial Translocation and Opening of the Mitochondrial Permeability Transition Pore.
Shah SS, Lannon H, Dias L, Zhang JY, Alper SL, Pollak MR, Friedman DJ. Shah SS, et al. J Am Soc Nephrol. 2019 Dec;30(12):2355-2368. doi: 10.1681/ASN.2019020114. Epub 2019 Sep 26. J Am Soc Nephrol. 2019. PMID: 31558683
APOL1 risk variants cause podocytes injury through enhancing endoplasmic reticulum stress.
Wen H, Kumar V, Lan X, Shoshtari SSM, Eng JM, Zhou X, Wang F, Wang H, Skorecki K, Xing G, Wu G, Luo H, Malhotra A, Singhal PC. Wen H, et al. Biosci Rep. 2018 Aug 29;38(4):BSR20171713. doi: 10.1042/BSR20171713. Print 2018 Aug 31. Biosci Rep. 2018. PMID: 29967295 Free PMC article.
APOL1 Kidney-Risk Variants Induce Mitochondrial Fission.
Ma L, Ainsworth HC, Snipes JA, Murea M, Choi YA, Langefeld CD, Parks JS, Bharadwaj MS, Chou JW, Hemal AK, Petrovic S, Craddock AL, Cheng D, Hawkins GA, Miller LD, Hicks PJ, Saleem MA, Divers J, Molina AJA, Freedman BI. Ma L, et al. Kidney Int Rep. 2020 Mar 30;5(6):891-904. doi: 10.1016/j.ekir.2020.03.020. eCollection 2020 Jun. Kidney Int Rep. 2020. PMID: 32518871 Free PMC article.
APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Bruggeman LA, O'Toole JF, Sedor JR. Bruggeman LA, et al. Am J Physiol Renal Physiol. 2019 Jan 1;316(1):F1-F8. doi: 10.1152/ajprenal.00426.2018. Epub 2018 Oct 17. Am J Physiol Renal Physiol. 2019. PMID: 30332315 Free PMC article. Review.
Protein domains of APOL1 and its risk variants.
Lan X, Wen H, Lederman R, Malhotra A, Mikulak J, Popik W, Skorecki K, Singhal PC. Lan X, et al. Exp Mol Pathol. 2015 Aug;99(1):139-44. doi: 10.1016/j.yexmp.2015.06.003. Epub 2015 Jun 17. Exp Mol Pathol. 2015. PMID: 26091559 Free PMC article.
Recruitment of APOL1 kidney disease risk variants to lipid droplets attenuates cell toxicity.
Chun J, Zhang JY, Wilkins MS, Subramanian B, Riella C, Magraner JM, Alper SL, Friedman DJ, Pollak MR. Chun J, et al. Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3712-3721. doi: 10.1073/pnas.1820414116. Epub 2019 Feb 7. Proc Natl Acad Sci U S A. 2019. PMID: 30733285 Free PMC article.
101 results
Jump to page
Feedback